---
$id: https://graph.org.ai/products/commodity/51351516
$type: Product
source: UNSPSC
code: "51351516"
title: "Anagestone"
class: "51351500"
classTitle: "Estrogen, progestin, or internal contraceptive pregnanes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Anagestone

**UNSPSC Code**: 51351516
**Class**: [Estrogen, progestin, or internal contraceptive pregnanes](Estrogen, progestin, or internal contraceptive pregnanes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic progestin with the molecular formula C22H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8FB38IU3G, chemically known as 17-hydroxy-6.alpha.-methylpregn-4-en-20-one but generally known as anagestone, which bears US NIH Compound Identifier 160650. European Medicines Agency schedules Anagestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05498MIG. Most nations schedule anagestone under HS 29372300 and SITC 54153. As of Q4 2014, ANAGESTONE remains the US FDA Preferred Term for this commodity. Anagestone bears US NLM identifiers UMLS ID C0051808 and NCI Concept Code C79752. SMILES: CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CCCC4)C.

